בלסטווין טבע

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

VINBLASTINE SULFATE

MAH:

ABIC MARKETING LTD, ISRAEL

ATC_code:

L01CA01

pharmaceutical_form:

תמיסה להזרקה

composition:

VINBLASTINE SULFATE 1 MG / 1 ML

administration_route:

תוך-ורידי

prescription_type:

אין צורך במרשם

manufactured_by:

PHARMACHEMIE B.V., (TEVA GROUP) ,THE NETHERLANDS

therapeutic_group:

VINBLASTINE

therapeutic_area:

VINBLASTINE

therapeutic_indication:

Vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:Frequently Responsive Malignancies :• Generalized Hodgkin's disease (Stages III and IV, Ann Arbor modification of Rye staging system)• Non-Hodgkin's lymphoma: - Reticulum-cell sarcoma - Lymphosarcoma• Mycosis fungoides.• Neuroblastoma.• Histiocytosis X.Less Frequently Responsive Malignancies :• Choriocarcinoma resistant to other chemotherapeutic agents.• Embryonal carcinoma of the testis.• Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

authorization_date:

2016-08-31